Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Xtant Medical Holdings (XTNT) FCF Margin (2016 - 2025)

Xtant Medical Holdings has reported FCF Margin over the past 16 years, most recently at 12.58% for Q3 2025.

  • Quarterly FCF Margin rose 2626.0% to 12.58% in Q3 2025 from the year-ago period, while the trailing twelve-month figure was 3.89% through Sep 2025, up 1906.0% year-over-year, with the annual reading at 13.65% for FY2024, 164.0% down from the prior year.
  • FCF Margin was 12.58% for Q3 2025 at Xtant Medical Holdings, up from 2.57% in the prior quarter.
  • Over five years, FCF Margin peaked at 12.58% in Q3 2025 and troughed at 23.42% in Q1 2024.
  • The 5-year median for FCF Margin is 11.49% (2022), against an average of 8.14%.
  • Year-over-year, FCF Margin crashed -1643bps in 2022 and then skyrocketed 2626bps in 2025.
  • A 5-year view of FCF Margin shows it stood at 1.45% in 2021, then crashed by -1129bps to 17.88% in 2022, then skyrocketed by 75bps to 4.55% in 2023, then skyrocketed by 100bps to 0.02% in 2024, then soared by 56713bps to 12.58% in 2025.
  • Per Business Quant, the three most recent readings for XTNT's FCF Margin are 12.58% (Q3 2025), 2.57% (Q2 2025), and 0.26% (Q1 2025).